Savara Inc. Releases Q1 2025 Financial Results and Business Insights
May 14, 2025 - 00:54
LANGHORNE, Pa., May 13, 2025 – Savara Inc., a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, has announced its financial results for the first quarter ending March 31, 2025. The company reported a net loss attributable to common stockholders of $12.5 million, compared to a loss of $10 million in the same period last year. This increase in loss is primarily due to heightened research and development expenses as Savara advances its pipeline of innovative therapies.
During the quarter, the company made significant progress in its clinical trials, particularly with its lead product candidate. The management expressed optimism regarding upcoming data readouts and emphasized their commitment to addressing unmet needs in the respiratory disease space.
Savara's strategic focus remains on leveraging its unique drug delivery technology to enhance patient outcomes. The company is actively exploring partnerships and collaborations to expand its reach and accelerate the development of its promising therapies.
MORE NEWS
July 10, 2026 - 06:15
Gov. Kelly Ayotte signs tax credit to incentivize businesses to invest in employee childcareNew Hampshire Governor Kelly Ayotte held a ceremonial bill signing on Thursday to promote a recently enacted tax credit designed to encourage businesses to invest in childcare for their workers....
July 9, 2026 - 18:31
Topaz vs. Evoque: New head-to-head study for TTVR devices now underwayA new clinical study is now underway to directly compare two leading transcatheter tricuspid valve replacement (TTVR) systems. The trial will pit the redesigned Topaz device from TRiCares against...
July 9, 2026 - 02:11
West Orange School Business Administrator on Paid Leave After $13.5M DeficitThe West Orange school district has placed its business administrator on paid administrative leave after the discovery of a $13.5 million budget deficit, according to documents released to...
July 8, 2026 - 04:18
State Establishes NC Economic Forecasting Initiative at UNC Kenan-Flagler Business SchoolThe North Carolina General Assembly has set aside $3 million to create the North Carolina Economic Forecasting Initiative, or NCEFI. The money, drawn from the state budget for the 2026-27 fiscal...